13F HOLDINGS REPORT
HealthInvest Partners AB
Quarter ended Q4 2025 · Filed February 6, 2026 · Accession 0001381843-26-000002
Total Value
$313.4M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 31,133 | $33.5M | 10.67% |
| 2 | AbbVie Inc | ABBV | 108,181 | $24.7M | 7.89% |
| 3 | Merck & Co. Inc | MRK | 195,768 | $20.6M | 6.57% |
| 4 | Thermo Fisher Scientific Corp | TMO | 29,915 | $17.3M | 5.53% |
| 5 | Neurocrine Biosciences Inc | NBIX | 94,796 | $13.4M | 4.29% |
| 6 | Intuitive Surgical Inc | ISRG | 22,322 | $12.6M | 4.03% |
| 7 | BEONE MEDICINES LTD-ADR | BEIGF | 40,432 | $12.3M | 3.92% |
| 8 | Bridgebio Pharma Inc | BBIO | 141,296 | $10.8M | 3.45% |
| 9 | Vertex Pharmaceuticals Inc | VRTX | 22,984 | $10.4M | 3.32% |
| 10 | Boston Scientific Corp | BSX | 108,682 | $10.4M | 3.31% |
| 11 | Stryker Corporation | SYK | 26,835 | $9.4M | 3.01% |
| 12 | CVS HEALTH CORP | CVS | 106,518 | $8.5M | 2.70% |
| 13 | Krystal Biotech, Inc | KRYS | 33,853 | $8.3M | 2.66% |
| 14 | Cencora Inc | COR | 23,773 | $8.0M | 2.56% |
| 15 | IONIS PHARMACEUTICALS INC | IONS | 92,377 | $7.3M | 2.33% |
| 16 | REVOLUTION Medicines Inc | RVMDW | 90,184 | $7.2M | 2.29% |
| 17 | Amgen Inc | AMGN | 21,903 | $7.2M | 2.29% |
| 18 | Mirum Pharmaceuticals Inc | MIRM | 89,685 | $7.1M | 2.26% |
| 19 | INCYTE CORP | INCY | 70,851 | $7.0M | 2.23% |
| 20 | NewAmsterdam Pharma Co NV | NAMSW | 197,036 | $6.9M | 2.21% |
| 21 | Alkermes PLC | ALKS | 242,473 | $6.8M | 2.16% |
| 22 | iRhythm Technologies Inc | IRTC | 37,579 | $6.7M | 2.13% |
| 23 | Gilead Sciences Inc | GILD | 50,796 | $6.2M | 1.99% |
| 24 | UFP Technologies Inc | UFPT | 22,986 | $5.1M | 1.63% |
| 25 | INSMED INC | INSM | 27,873 | $4.9M | 1.55% |
| 26 | Cardinal Health Inc | CAH | 23,470 | $4.8M | 1.54% |
| 27 | ABIVAX SA | AAVXF | 31,590 | $4.3M | 1.36% |
| 28 | CELCUITY INC | CELC | 41,831 | $4.2M | 1.33% |
| 29 | Disc medicine inc | IRON | 47,967 | $3.8M | 1.22% |
| 30 | IDEAYA BIOSCIENCES INC | IDYA | 97,438 | $3.4M | 1.07% |
| 31 | Universal Health Services Inc | UNH | 14,636 | $3.2M | 1.02% |
| 32 | COMPASS THERAPEUTICS INC | CMPX | 584,332 | $3.1M | 1.00% |
| 33 | Soleno Therapeutics Inc | SLNO | 62,735 | $2.9M | 0.93% |
| 34 | Arcellx Inc | ACLX | 41,717 | $2.7M | 0.87% |
| 35 | Dexcom Inc | DXCM | 39,722 | $2.6M | 0.84% |
| 36 | Autolus Therapeutics PLC | AUTL | 1,169,634 | $2.3M | 0.74% |
| 37 | BICARA THERAPEUTICS INC | BCAX | 111,363 | $1.9M | 0.60% |
| 38 | Corbus Pharmaceuticals Holding | CRBP | 107,255 | $873,055 | 0.28% |
| 39 | PYXIS ONCOLOGY INC | PYXS | 617,245 | $709,831 | 0.23% |